Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant- Dominant Periods in Korea

被引:23
|
作者
Choi, Soo -Han [1 ]
Choi, Jae Hong [2 ]
Lee, Joon Kee [3 ]
Eun, Byung-Wook [4 ]
Ha Song, Seung [5 ]
Ahn, Bin [5 ]
Kim, Ye Kyung [5 ]
Yun, Ki Wook [5 ,6 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Pediat, Busan, South Korea
[2] Jeju Natl Univ, Sch Med, Dept Pediat, Jeju, South Korea
[3] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Pediat, Cheongju, South Korea
[4] Nowon Eulji Univ Hosp, Dept Pediat, Seoul, South Korea
[5] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea
关键词
COVID-19; SARS-CoV-2; Variants; SARS-CoV-2 Omicron Variant; SARS-CoV-2 Delta Variant; Child; Adolescent; LABORATORY-CONFIRMED COVID-19-COVID-NET; 14; STATES; HOSPITALIZATIONS; TRANSMISSION;
D O I
10.3346/jkms.2023.38.e65
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Data on the clinical characteristics of pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection are limited. We aimed to evaluate the clinical features and outcomes of children with SARS-CoV-2 infection before and after omicron variant dominance in Korea.Methods: A multicenter retrospective cohort study was conducted in hospitalized patients aged <= 18 years with laboratory-confirmed SARS-CoV-2 infection at five university hospitals in South Korea. The study periods were divided into the delta (from August 23, 2021 to January 2, 2022) and omicron (from January 30 to March 31, 2022).Results: In total, 612 hospitalized patients were identified (211, delta; 401, omicron). During the omicron and delta periods, the proportions of individuals with serious illness (moderate, severe, and critical severity) were 21.2% and 11.8%, respectively (P = 0.034). Compared with the delta period, the proportions of patients with moderate illness increased significantly in the age groups of 0-4 years (14.2% vs. 3.4%) and 5-11 years (18.6% vs. 4.2%) during the omicron period. During the two periods, the proportions of patients with complex chronic diseases (delta, 16.0% vs. 4.3%, P = 0.040; omicron, 27.1% vs. 12.7%; P = 0.002), respiratory diseases except for asthma (delta, 8.0% vs. 0.0%, P = 0.013; omicron, 9.4% vs. 1.6%; P = 0.001), and neurologic diseases (delta, 28.0% vs. 3.2%, P < 0.001; omicron, 40.0% vs. 5.1%, P < 0.001) were significantly higher in patients with serious illness than in those with non -serious illness. During the delta period, the risk for serious illness was higher among patients with obesity (adjusted odds ratio [aOR], 8.18; 95% confidence interval [CI], 2.80-27.36) and neurologic diseases (aOR, 39.43; 95% CI, 6.90-268.3) and aged 12-18 years (aOR, 3.92; 95% CI, 1.46-10.85). However, the presence of neurologic disease (aOR, 9.80; 95% CI, 4.50-22.57) was the only risk factor for serious illness during the omicron period. During the omicron period, the proportions of patients with croup (11.0% vs. 0.5%) and seizures (13.2% vs. 2.8%) increased significantly compared with the delta period.Conclusion: Compared with the delta period, the proportions of young children and patients with complex comorbidities were higher during the omicron period in Korea. Patients with complex chronic diseases, especially neurologic diseases, had a high risk of severe coronavirus disease 2019 in the two distinct variant-dominant periods.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Clinical characteristics of 30 children with severe acute SARS-CoV-2 infection
    Li, Weijun
    Zhu, Danping
    Xiao, Weiqiang
    Liang, Defeng
    Deng, Huarong
    Zheng, Jipeng
    Wang, Qiang
    Liu, Guangming
    Li, Peiqing
    HONG KONG JOURNAL OF EMERGENCY MEDICINE, 2024, 31 (06) : 285 - 298
  • [42] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [43] SARS-CoV-2 Omicron variant shedding during respiratory activities
    Sen Tan, Kai
    Ong, Sean Wei Xiang
    Koh, Ming Hui
    Tay, Douglas Jie Wen
    Aw, Daryl Zheng Hao
    Nah, Yi Wei
    Abdullah, Mohammed Ridzwan Bin
    Coleman, Kristen K.
    Milton, Donald K.
    Chu, Justin Jang Hann
    Chow, Vincent T. K.
    Tambyah, Paul Anantharajah
    Tham, Kwok Wai
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 131 : 19 - 25
  • [44] Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection
    Tso, Winnie Wan-Yee
    Kwan, Mike Yat-Wah
    Kwok, Janette Siu-Yin
    Tsang, Jessica Oi-Ling
    Yip, Cyril Chik-Yan
    Leung, Lok-Kan
    Li, Cuixin
    Wang, Yuliang
    Chow, Mathew Siu-Chun
    Tsang, Anita Man-Ching
    Chim, Stella
    Chow, Chin-Ying
    Ho, Alvin Chi-Chung
    Chan, Sophelia Hoi-Shan
    Tai, Shuk-Mui
    Lee, Wing-Cheong
    Chan, Victor Chi-Man
    Yau, Eric Kin-Cheong
    Sun, Jacquelyne Ka-Li
    Chow, Hei-Man
    Lau, Yu-Lung
    Ip, Patrick
    Chan, Jasper Fuk-Woo
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (07)
  • [45] Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons
    Chaguza, Chrispin
    Coppi, Andreas
    Earnest, Rebecca
    Ferguson, David
    Kerantzas, Nicholas
    Warner, Frederick
    Young, H. Patrick
    Breban, Mallery, I
    Billig, Kendall
    Koch, Robert Tobias
    Pham, Kien
    Kalinich, Chaney C.
    Ott, Isabel M.
    Fauver, Joseph R.
    Hahn, Anne M.
    Tikhonova, Irina R.
    Castaldi, Christopher
    De Kumar, Bony
    Pettker, Christian M.
    Warren, Joshua L.
    Weinberger, Daniel M.
    Landry, Marie L.
    Peaper, David R.
    Schulz, Wade
    Vogels, Chantal B. F.
    Grubaugh, Nathan D.
    MED, 2022, 3 (05): : 325 - +
  • [46] COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)
    Arashiro, Takeshi
    Arima, Yuzo
    Muraoka, Hirokazu
    Sato, Akihiro
    Oba, Kunihiro
    Uehara, Yuki
    Arioka, Hiroko
    Yanai, Hideki
    Kuramochi, Jin
    Ihara, Genei
    Chubachi, Kumi
    Yanagisawa, Naoki
    Nagura, Yoshito
    Kato, Yasuyuki
    Ueda, Akihiro
    Numata, Akira
    Kato, Hideaki
    Ishii, Koji
    Ooki, Takao
    Oka, Hideaki
    Nishida, Yusuke
    Stucky, Ashley
    Smith, Chris
    Hibberd, Martin
    Ariyoshi, Koya
    Suzuki, Motoi
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E108 - E115
  • [47] Differential clinical characteristics and performance of home antigen tests between parents and children after household transmission of SARS-CoV-2 during the Omicron variant pandemic
    Chen, Szu-Han
    Wu, Jhong-Lin
    Liu, Yun-Chung
    Yen, Ting-Yu
    Lu, Chun-Yi
    Chang, Luan-Yin
    Lee, Wang-Tso
    Chen, Jong-Min
    Lee, Ping-Ing
    Huang, Li -Min
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 301 - 306
  • [48] Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021
    Jang, Tyng-Yuan
    Wang, Hsin-Hui
    Huang, Chung-Feng
    Dai, Chia-Yen
    Huang, Jee-Fu
    Chuang, Wan-Long
    Kuo, Cheng-Yu
    Yu, Ming-Lung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (09) : 1767 - 1772
  • [49] Mathematical modeling for Delta and Omicron variant of SARS-CoV-2 transmission dynamics in Greece
    Liossi, Sofia
    Tsiambas, E.
    Maipas, S.
    Papageorgiou, E.
    Lazaris, A.
    Kavantzas, N.
    INFECTIOUS DISEASE MODELLING, 2023, 8 (03) : 794 - 805
  • [50] Comparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron
    Kirca, Fusun
    Aydogan, Sibel
    Gozalan, Aysegul
    Kayipmaz, Afsin Emre
    Ozdemir, Fatma Ayca Edis
    Tekce, Yasemin Tezer
    Beser, Ipek Omay
    Gun, Pinar
    Okten, Riza Sarper
    Dinc, Bedia
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (10): : 1476 - 1480